Breaking Down Gilead Sciences: 10 Analysts Share Their Views
Portfolio Pulse from Benzinga Insights
Gilead Sciences (NASDAQ:GILD) has been analyzed by 10 analysts, revealing a range of sentiments from bullish to bearish. The average 12-month price target is $77.3, with a high of $93.00 and a low of $69.00. Recent analyst actions include several downgrades and maintained ratings, reflecting mixed views on the company's future performance.
July 22, 2024 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Gilead Sciences has received mixed analyst ratings, with recent downgrades and maintained ratings. The average 12-month price target is $77.3, slightly down from the previous $78.62. Analysts' views range from 'Outperform' to 'Neutral', reflecting uncertainty about the company's future performance.
The mixed analyst ratings and slight decrease in the average price target suggest a neutral short-term impact on Gilead Sciences' stock price. The range of sentiments from 'Outperform' to 'Neutral' indicates uncertainty among analysts about the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100